“…Targeted disruption of multiple ASD risk genes of diverse cellular functions in human iPSC-derived NPCs altered the proportion of actively dividing cells. Our findings are generally consistent with a series of individual findings across multiple model systems observing brain size changes for individual ASD risk gene perturbations (Bernier et al, 2014;Hoffman et al, 2016;Zhao et al, 2017;Willsey et al, 2020;Durak et al, 2016;Shen et al, 2015;Katayama et al, 2016) and with clinical observations of gross changes in head size in some individuals with ASD, including in those carrying variants in genes studied here, for example, CHD8, DYRK1A, and POGZ (Ji et al, 2015;Evers et al, 2017;van Bon et al, 2016;Yasin et al, 2019;Bernier et al, 2014;O'Roak et al, 2012a;Ye et al, 2015). The direction and magnitude of forebrain size changes likely depend on the strength of the genetic perturbation, the developmental stage at which size is assayed, and the molecular function of the gene.…”